Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2015, Article ID 801053, 9 pages
http://dx.doi.org/10.1155/2015/801053
Research Article

Role of Mas Receptor Antagonist A799 in Renal Blood Flow Response to Ang 1-7 after Bradykinin Administration in Ovariectomized Estradiol-Treated Rats

1Water & Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan 81745, Iran
2Department of Physiology, Isfahan University of Medical Sciences, Isfahan 81745, Iran
3IsfahanMN Institute of Basic & Applied Sciences Research, Isfahan 81546, Iran

Received 31 May 2015; Revised 11 August 2015; Accepted 12 August 2015

Academic Editor: Thérèse Di Paolo-Chênevert

Copyright © 2015 Aghdas Dehghani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Gouva and A. Tsatsoulis, “The role of estrogens in cardiovascular disease in the aftermath of clinical trials,” Hormones, vol. 3, no. 3, pp. 171–183, 2004. View at Publisher · View at Google Scholar
  2. M. C. Chappell, A. C. Marshall, E. M. Alzayadneh, H. A. Shaltout, and D. I. Diz, “Update on the angiotensin converting enzyme 2-angiotensin (1–7)-Mas receptor axis: fetal programing, sex differences, and intracellular pathways,” Frontiers in Endocrinology, vol. 4, article 201, 2013. View at Publisher · View at Google Scholar
  3. S. L. Seliger, C. Davis, and C. Stehman-Breen, “Gender and the progression of renal disease,” Current Opinion in Nephrology and Hypertension, vol. 10, no. 2, pp. 219–225, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Sampson, K. M. Moritz, E. S. Jones, R. L. Flower, R. E. Widdop, and K. M. Denton, “Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats,” Hypertension, vol. 52, no. 4, pp. 666–671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Armando, M. Jezova, A. V. Juorio et al., “Estrogen upregulates renal angiotensin II AT2 receptors,” The American Journal of Physiology—Renal Physiology, vol. 283, no. 5, pp. F934–F943, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Ji, S. Menini, W. Zheng, C. Pesce, X. Wu, and K. Sandberg, “Role of angiotensin-converting enzyme 2 and angiotensin(1–7) in 17β-oestradiol regulation of renal pathology in renal wrap hypertension in rats,” Experimental Physiology, vol. 93, no. 5, pp. 648–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Madeddu, C. Emanueli, M. V. Varoni et al., “Regulation of bradykinin B2-receptor expression by oestrogen,” British Journal of Pharmacology, vol. 121, no. 8, pp. 1763–1769, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Sumino, S. Ichikawa, T. Kanda et al., “Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin,” American Journal of Hypertension, vol. 12, no. 10, pp. 1044–1047, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Ferrario and S. N. Iyer, “Angiotensin-(1–7): a bioactive fragment of the renin-angiotensin system,” Regulatory Peptides, vol. 78, no. 1–3, pp. 13–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Joyner, L. A. A. Neves, J. P. Granger et al., “Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 293, no. 1, pp. R169–R177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. S. Santos, A. C. Simoes e Silva, C. Maric et al., “Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8258–8263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Zhu, J. Zhong, S. Zhu, D. Liu, M. van der Giet, and M. Tepel, “Angiotensin-(1–7) inhibits angiotensin II-induced signal transduction,” Journal of Cardiovascular Pharmacology, vol. 40, no. 5, pp. 693–700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Iwai and M. Horiuchi, “Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis,” Hypertension Research, vol. 32, no. 7, pp. 533–536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. S. Santos, A. J. Ferreira, and A. C. S. e Silva, “Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis,” Experimental Physiology, vol. 93, no. 5, pp. 519–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Luque, P. Martin, N. Martell, C. Fernandez, K. B. Brosnihan, and C. M. Ferrario, “Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension,” Journal of Hypertension, vol. 14, no. 6, pp. 799–805, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. Ferrario, J. Jessup, P. E. Gallagher et al., “Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors,” Kidney International, vol. 68, no. 5, pp. 2189–2196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Donoghue, F. Hsieh, E. Baronas et al., “A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9,” Circulation Research, vol. 87, no. 5, pp. e1–e9, 2000. View at Google Scholar
  18. M. C. Chappell, A. J. Allred, and C. M. Ferrario, “Pathways of angiotensin-(1-7) metabolism in the kidney,” Nephrology Dialysis Transplantation, vol. 16, supplement 1, pp. 22–26, 2001. View at Google Scholar · View at Scopus
  19. M. C. Chappell, N. T. Pirro, A. Sykes, and C. M. Ferrario, “Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme,” Hypertension, vol. 31, no. 1, pp. 362–367, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. H. S. Margolius, “Kallikreins and kinins: molecular characteristics and cellular and tissue responses,” Diabetes, vol. 45, supplement 1, pp. S14–S19, 1996. View at Google Scholar · View at Scopus
  21. K. D. Bhoola, C. D. Figueroa, and K. Worthy, “Bioregulation of kinins: kallikreins, kininogens, and kininases,” Pharmacological Reviews, vol. 44, no. 1, pp. 1–80, 1992. View at Google Scholar · View at Scopus
  22. D. J. Campbell, “Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides,” Brazilian Journal of Medical and Biological Research, vol. 33, no. 6, pp. 665–677, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. L. Hébert, D. Regoli, H. Xiong, M. D. Breyer, and G. E. Plante, “Bradykinin B2 type receptor activation regulates fluid and electrolyte transport in the rabbit kidney,” Peptides, vol. 26, no. 8, pp. 1308–1316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. N.-E. Rhaleb, X.-P. Yang, and O. A. Carretero, “The Kallikrein-kinin system as a regulator of cardiovascular and renal function,” Comprehensive Physiology, vol. 1, no. 2, pp. 971–993, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-V. Mombouli and P. M. Vanhoutte, “Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition,” Journal of Cardiovascular Pharmacology, vol. 20, no. 9, pp. S74–S82, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. E. G. Erdös, F. Tan, and R. A. Skidgel, “Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function,” Hypertension, vol. 55, no. 2, pp. 214–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. B. Brosnihan, P. Li, and C. M. Ferrario, “Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide,” Hypertension, vol. 27, no. 3, pp. 523–528, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Abbas, G. Gorelik, L. A. Carbini, and A. G. Scicli, “Angiotensin-(1–7) induces bradykinin-mediated hypotensive responses in anesthetized rats,” Hypertension, vol. 30, no. 2, pp. 217–221, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Oliveira, Z. B. Fortes, R. A. S. Santos, M. C. Kosla, and M. H. C. De Carvalho, “Synergistic effect of angiotensin-(1–7) on bradykinin arteriolar dilation in vivo,” Peptides, vol. 20, no. 10, pp. 1195–1201, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. R. W. Schrier and W. Wang, “Acute renal failure and sepsis,” The New England Journal of Medicine, vol. 351, no. 2, pp. 159–169, 2004. View at Google Scholar
  31. C. J. Lote, L. Harper, and C. O. S. Savage, “Mechanisms of acute renal failure,” British Journal of Anaesthesia, vol. 77, no. 1, pp. 82–89, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. V. E. Torres, B. F. King, A. B. Chapman et al., “Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 1, pp. 112–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. K. M. Hoagland, D. A. Maddox, and D. S. Martin, “Bradykinin B2-receptors mediate the pressor and renal hemodynamic effects of intravenous bradykinin in conscious rats,” Journal of the Autonomic Nervous System, vol. 75, no. 1, pp. 7–15, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Nematbakhsh and T. Safari, “Role of Mas receptor in renal blood flow response to angiotensin (1–7) in male and female rats,” General Physiology and Biophysics, vol. 33, no. 3, pp. 365–372, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. K. D. da Silveira, K. S. P. Bosco, L. R. L. Diniz et al., “ACE2-angiotensin-(1–7)-Mas axis in renal ischaemia/reperfusion injury in rats,” Clinical Science, vol. 119, no. 9, pp. 385–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Bachmann and P. Mundel, “Nitric oxide in the kidney: synthesis, localization, and function,” American Journal of Kidney Diseases, vol. 24, no. 1, pp. 112–129, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Pezeshki, M. Nematbakhsh, S. Mazaheri et al., “Estrogen abolishes protective effect of erythropoietin against cisplatin-induced nephrotoxicity in ovariectomized rats,” ISRN Oncology, vol. 2012, Article ID 890310, 7 pages, 2012. View at Publisher · View at Google Scholar
  38. S. Bosnyak, E. S. Jones, A. Christopoulos, M.-I. Aguilar, W. G. Thomas, and R. E. Widdop, “Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors,” Clinical Science, vol. 121, no. 7, pp. 297–303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Madeddu, N. Glorioso, M. Maioli et al., “Regulation of rat renal kallikrein expression by estrogen and progesterone,” Journal of Hypertension, vol. 9, no. 6, pp. S244–S245, 1991. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Proudler, D. Crook, J. C. Stevenson, A. I. H. Ahmed, J. M. Rymer, and I. Fogelman, “Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women,” The Lancet, vol. 346, no. 8967, pp. 89–90, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Wang, J. A. Jessup, Z. Zhao et al., “Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2. Lewis rats,” PLoS ONE, vol. 8, no. 10, Article ID e76992, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. L. A. A. Neves, D. B. Averill, C. M. Ferrario, J. L. Aschner, and K. B. Brosnihan, “Vascular responses to angiotensin-(–7) during the estrous cycle,” Endocrine, vol. 24, no. 2, pp. 161–165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-C. Veille, P. Li, J. C. Eisenach, A. G. Massmann, and J. P. Figueroa, “Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro,” American Journal of Obstetrics and Gynecology, vol. 174, no. 3, pp. 1043–1049, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. E. A. van der Wouden, P. Ochodnický, R. P. E. van Dokkum et al., “The role of angiotensin(1–7) in renal vasculature of the rat,” Journal of Hypertension, vol. 24, no. 10, pp. 1971–1978, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Vallon, N. Heyne, K. Richter, M. C. Khosla, and K. Fechter, “[7-D-ALA]-angiotensin 1–7 blocks renal actions of angiotensin 1–7 in the anesthetized rat,” Journal of Cardiovascular Pharmacology, vol. 32, no. 1, pp. 164–167, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. R. K. Handa, C. M. Ferrario, and J. W. Strandhoy, “Renal actions of angiotensin-(1–7): in vivo and in vitro studies,” American Journal of Physiology, vol. 270, no. 1, pp. F141–F147, 1996. View at Google Scholar · View at Scopus
  47. Y. Ren, J. L. Garvin, and O. A. Carretero, “Vasodilator action of angiotensin-(1–7) on isolated rabbit afferent arterioles,” Hypertension, vol. 39, no. 3, pp. 799–802, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. W. O. Sampaio, A. A. S. Nascimento, and R. A. S. Santos, “Systemic and regional hemodynamic effects of angiotensin-(1–7) in rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 6, pp. H1985–H1994, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. G. A. Botelho-Santos, W. O. Sampaio, T. L. Reudelhuber, M. Bader, M. J. Campagnole-Santos, and R. A. S. Dos Santos, “Expression of an angiotensin-(1–7)-producing fusion protein in rats induced marked changes in regional vascular resistance,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2485–H2490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. I. F. Benter, D. I. Diz, and C. M. Ferrario, “Cardiovascular actions of angiotensin (1–7),” Peptides, vol. 14, no. 4, pp. 679–684, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. S. V. B. Pinheiro, A. J. Ferreira, G. T. Kitten et al., “Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria,” Kidney International, vol. 75, no. 11, pp. 1184–1193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. A. K. Sampson, K. M. Moritz, and K. M. Denton, “Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats,” Gender Medicine, vol. 9, no. 1, pp. 21–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Ren, J. Garvin, and O. A. Carretero, “Mechanism involved in bradykinin-induced efferent arteriole dilation,” Kidney International, vol. 62, no. 2, pp. 544–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. L. G. Navar, E. W. Inscho, D. S. A. Majid, J. D. Imig, L. M. Harrison-Bernard, and K. D. Mitchell, “Paracrine regulation of the renal microcirculation,” Physiological Reviews, vol. 76, no. 2, pp. 425–536, 1996. View at Google Scholar · View at Scopus
  55. B. Badzyńska and J. Sadowski, “Differential action of bradykinin on intrarenal regional perfusion in the rat: waning effect in the cortex and major impact in the medulla,” The Journal of Physiology, vol. 587, no. 15, pp. 3943–3953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Hock, K. Wirth, U. Albus et al., “Hoe 140 a new potent and long acting bradykininantagonist: in vitro studies,” British Journal of Pharmacology, vol. 102, no. 3, pp. 769–773, 1991. View at Google Scholar
  57. F. Gobeil, W. Neugebauer, C. Filteau et al., “Structure-activity studies of B1 receptor-related peptides. Antagonists,” Hypertension, vol. 28, no. 5, pp. 833–839, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Bagaté, L. Develioglu, J.-L. Imbs, B. Michel, J.-J. Helwig, and M. Barthelmebs, “Vascular kinin B1 and B2 receptor-mediated effects in the rat isolated perfused kidney—differential regulations,” British Journal of Pharmacology, vol. 128, no. 8, pp. 1643–1650, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. K. G. Hofbauer, H. Dienemann, P. Forgiarini, R. Stalder, and J. M. Wood, “Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins,” General Pharmacology: The Vascular System, vol. 14, no. 1, pp. 145–147, 1983. View at Publisher · View at Google Scholar · View at Scopus
  60. A. F. Milia, V. Gross, R. Plehm, J. A. De Silva Jr., M. Bader, and F. C. Luft, “Normal blood pressure and renal function in mice lacking the bradykinin B2 receptor,” Hypertension, vol. 37, no. 6, pp. 1473–1479, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Peiró, S. Vallejo, F. Gembardt et al., “Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function,” Journal of Hypertension, vol. 25, no. 12, pp. 2421–2425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. D. M. R. Silva, H. R. Vianna, S. F. Cortes, M. J. Campagnole-Santos, R. A. S. Santos, and V. S. Lemos, “Evidence for a new angiotensin-(1–7) receptor subtype in the aorta of Sprague-Dawley rats,” Peptides, vol. 28, no. 3, pp. 702–707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Peiró, S. Vallejo, F. Gembardt et al., “Complete blockade of the vasorelaxant effects of angiotensin-(1–7) and bradykinin in murine microvessels by antagonists of the receptor Mas,” The Journal of Physiology, vol. 591, no. 9, pp. 2275–2285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. P. E. Walters, T. A. Gaspari, and R. E. Widdop, “Angiotensin-(1–7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats,” Hypertension, vol. 45, no. 5, pp. 960–966, 2005. View at Publisher · View at Google Scholar · View at Scopus